The Sprague Lab at MUSC

Improving Health, One Molecule at a Time

Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types


Journal article


Rachel A. Jones Lipinski, Jennifer S. Stancill, Raymundo Nunez, Sarah L. Wynia-Smith, Daniel J. Sprague, Joshua A. Nord, Amir Bird, John A. Corbett, Brian C. Smith
American Journal of Physiology -- Regulatory, Integrative and Comparative Physiology, 2024

Cite

Cite

APA   Click to copy
Lipinski, R. A. J., Stancill, J. S., Nunez, R., Wynia-Smith, S. L., Sprague, D. J., Nord, J. A., … Smith, B. C. (2024). Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types. American Journal of Physiology -- Regulatory, Integrative and Comparative Physiology.


Chicago/Turabian   Click to copy
Lipinski, Rachel A. Jones, Jennifer S. Stancill, Raymundo Nunez, Sarah L. Wynia-Smith, Daniel J. Sprague, Joshua A. Nord, Amir Bird, John A. Corbett, and Brian C. Smith. “Zinc-Chelating BET Bromodomain Inhibitors Equally Target Islet Endocrine Cell Types.” American Journal of Physiology -- Regulatory, Integrative and Comparative Physiology (2024).


MLA   Click to copy
Lipinski, Rachel A. Jones, et al. “Zinc-Chelating BET Bromodomain Inhibitors Equally Target Islet Endocrine Cell Types.” American Journal of Physiology -- Regulatory, Integrative and Comparative Physiology, 2024.


BibTeX   Click to copy

@article{rachel2024a,
  title = {Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types},
  year = {2024},
  journal = {American Journal of Physiology -- Regulatory, Integrative and Comparative Physiology},
  author = {Lipinski, Rachel A. Jones and Stancill, Jennifer S. and Nunez, Raymundo and Wynia-Smith, Sarah L. and Sprague, Daniel J. and Nord, Joshua A. and Bird, Amir and Corbett, John A. and Smith, Brian C.}
}





Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in